Tanaka, Yoshiya
Article History
First Online: 10 August 2017
Competing interests
: Y.T. has received consulting fees, speaking fees and/or honoraria from Astellas, Bristol-Myers Squibb, Chugai Pharma, Daiichi Sankyo, Eli Lilly, Janssen, Mitsubishi-Tanabe Pharma, Pfizer, Sanofi, UCB and YL Biologics and has received research grants from Abbvie, Astellas, Bristol-Myers Squibb, Chugai Pharma, Daiichi Sankyo, Eisai, Kyowa Hakko Kirin, Mitsubishi-Tanabe, MSD, Ono Pharmaceutical, Pfizer and Takeda.